Australia markets close in 1 hour 20 minutes

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
108.22+0.60 (+0.56%)
At close: 4:04PM EST

108.23 +0.01 (0.01%)
After hours: 5:28PM EST

Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Cash flows from operating activities
Net income
3,382,000
3,687,000
2,368,000
477,000
1,400,000
Depreciation & amortisation
3,217,000
3,014,000
3,278,000
3,021,000
1,353,000
Stock-based compensation
533,000
519,000
477,000
406,000
310,000
Change in working capital
-1,425,000
-1,331,000
-148,000
1,915,000
-1,513,000
Accounts receivable
-261,000
-275,000
-190,000
-207,000
-177,000
Inventory
-701,000
-593,000
-514,000
249,000
-98,000
Accounts payable
-
220,000
747,000
615,000
-652,000
Other working capital
4,587,000
4,498,000
4,906,000
4,435,000
2,082,000
Other non-cash items
-
-
32,000
912,000
165,000
Net cash provided by operating activities
6,519,000
6,136,000
6,300,000
5,570,000
3,203,000
Cash flows from investing activities
Investments in property, plant and equipment
-1,932,000
-1,638,000
-1,394,000
-1,135,000
-1,121,000
Acquisitions, net
-31,000
-170,000
0
-17,183,000
-80,000
Purchases of investments
-
-103,000
-131,000
-210,000
-2,823,000
Sales/maturities of investments
-
21,000
73,000
129,000
3,709,000
Other investing activities
17,000
27,000
48,000
35,000
42,000
Net cash used for investing activities
-1,973,000
-1,815,000
-1,356,000
-9,618,000
-248,000
Cash flows from financing activities
Debt repayment
-4,250,000
-3,441,000
-12,433,000
-8,650,000
-12,000
Common stock repurchased
-738,000
-718,000
-238,000
-827,000
-522,000
Dividends paid
-2,487,000
-2,270,000
-1,974,000
-1,849,000
-1,539,000
Other financing activities
-
-
-
-13,000
-195,000
Net cash used provided by (used for) financing activities
-4,177,000
-4,289,000
-10,391,000
-5,281,000
11,147,000
Net change in cash
389,000
16,000
-5,563,000
-9,213,000
13,619,000
Cash at beginning of period
4,091,000
3,844,000
9,407,000
18,620,000
5,001,000
Cash at end of period
4,460,000
3,860,000
3,844,000
9,407,000
18,620,000
Free cash flow
Operating cash flow
6,519,000
6,136,000
6,300,000
5,570,000
3,203,000
Capital expenditure
-1,932,000
-1,638,000
-1,394,000
-1,135,000
-1,121,000
Free cash flow
4,587,000
4,498,000
4,906,000
4,435,000
2,082,000